Finance

Lists
VP4:FRA
Vistin Pharma ASA
€1.74
-1.69%
(-0.030) 1D
Sep 3, 8:22:24 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VP4...
Open
€1.74
High
€1.74
Low
€1.74
Avg. vol.
0.00
Volume
0.00
52-wk high
€2.10
52-wk low
€1.66
No. of employees
76
Open
€1.74
High
€1.74
Low
€1.74
Avg. vol.
0.00
Volume
0.00
52-wk high
€2.10
52-wk low
€1.66
No. of employees
76
About Vistin Pharma ASA
CEOKjell-Erik Nordby
Employees76
Founded1969
Headquarters-
SectorPharmaceutical industry
Websitevistin.com
Previous reportsAll values in NOK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NOK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
108.84M
110.74M
112.21M
100.20M
Cost of goods sold
31.52M
38.07M
39.38M
30.96M
Cost of revenue
31.52M
38.07M
39.38M
30.96M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.14M
11.50M
23.34M
23.42M
Operating expense
55.98M
51.85M
51.31M
53.19M
Total operating expenses
87.50M
89.93M
90.69M
84.15M
Operating income
21.34M
20.82M
21.53M
16.05M
Other non operating income
1.00K
41.00K
-
-3.00K
EBT including unusual items
23.75M
20.59M
27.55M
18.12M
EBT excluding unusual items
23.75M
20.59M
27.55M
18.12M
Income tax expense
5.22M
4.53M
6.06M
3.99M
Effective tax rate
22.00%
22.02%
22.00%
22.00%
Other operating expenses
22.14M
34.82M
22.17M
23.77M
Net income
18.52M
16.06M
21.49M
14.14M
Net profit margin
17.02%
14.50%
19.15%
14.11%
Earnings per share
-
-
-
-
Interest and investment income
4.76M
7.36M
11.54M
6.14M
Interest expense
-2.35M
-12.64M
-5.52M
-4.06M
Net interest expenses
2.41M
-5.28M
6.03M
2.08M
Depreciation and amortization charges
6.70M
5.53M
5.80M
6.01M
EBITDA
28.04M
25.41M
27.32M
22.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps